Results 141 to 150 of about 2,568,308 (394)
Molecular Oncology, EarlyView.Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh +5 more
wiley +1 more source
Relationship between corporate identity and corporate reputation: A case of a Malaysian higher education [PDF]
, 2007 Organizations need corporate identity for survival.This identity is developing through the projection of one positive image that will increase its public confidence about the quality and achievements of the organization.This paper attempts to identify ...
Abdul Rahman, Nik Adzrieman +2 more
core +1 more source
Molecular Oncology, EarlyView.Microglia (BV2) and IL‐4‐treated BMDMs promote astrocytoma clustering and inhibit tumor growth, not shown in other macrophage cells. In vivo, microglial co‐implantation enhances CD8+ T cell infiltration, elevates Granzyme B, lowers circulating MDSCs, and extends survival only in immune‐competent mice, but not in immune‐deficient mice.
Tzu‐Chieh Sun +5 more
wiley +1 more source
Drvna Industrija, 2010 In this paper we have researched the perception of corporate identity in wood processing and furniture manufacturing companies in Croatia and Slovakia. The research was conducted as a survey using questionnaires, which contained general information about
doaj
Surveillance and the Self: Understanding Privacy and Identity in Digital Environments
, 2019 The widespread use of internet enabled devices among contemporary US adults has given rise to a series of questions about issues of identity, privacy and group behaviors. The increasing use of algorithmic systems in social media and the attendant privacy
Standlee, Alecea Ritter
core
Corporate identity orientation and disorientation: A complexity theory perspective
, 2020 Luke Devereux +3 more
semanticscholar +1 more source
Organizational Identity Orientation and the Adoption of Corporate Social Responsibility: Symbolic, Selective, or Substantial? [PDF]
, 2012 Christopher Wickert, Antonino Vaccaro
openalex +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Molecular Oncology, EarlyView.Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
Molecular Oncology, EarlyView.A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira +14 more
wiley +1 more source